Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
A serious boom in the price of Bitcoin will not happen, according to a billionaire

A serious boom in the price of Bitcoin will not happen, according to a billionaire

Cryptodnes2024/06/30 10:55
By:Cryptodnes

Former PayPal CEO Peter Thiel has expressed skepticism about the likelihood of a major rise in Bitcoin's price from its current levels.

The billionaire who still holds BTC, though not as much as he thinks “should own', he's not sure where the next wave of buyers will come from now that Bitcoin already has its ETFs.

"I'm not sure the price will go up dramatically from now on. We got the ETF release and I don't know who else is going to buy it" said Thiel, founder of Founders Fund, in interview on CNBC on June 28.

It is likely that the price could still go up a bit, but it will be a volatile and bumpy ride.

READ MORE:
Bitcoin mining company CleanSpark announced a new deal for $155 million

Teal was before that mentioned , that is "underinvested” in BTC in October 2021, at a time when the cryptocurrency was climbing to its then all-time high of $69,000.

However, Thiel's Founders Fund boasts a remarkable track record with Bitcoin , making his first investment in the cryptocurrency in 2014 and making $1.8 billion just before the 2022 market crash.

The fund subsequently acquired another $100 million in BTC in 2023 when the price was below $30,000.

What I'm not so sure about is the question of the ideological foundational vision of Bitcoin - a crazed, crypto-anarchist, liberal and decentralized movement.

READ MORE:
Things could be getting worse for Bitcoin despite the bullish signals

"That's what I thought was great about it,” Thiel reflects on his initial introduction to Bitcoin.

However, he now believes that Bitcoin “it doesn't really work that way".

When the FBI people tell me they'd rather criminals use Bitcoin than $100 bills, that suggests that maybe it doesn't work quite as well as it's supposed to.

Bitcoin was designed to be a public and decentralized ledger, and its transactions were never intended to be completely untraceable like those in Monero and other privacy-oriented networks.

At the time of writing, Bitcoin is trading at $61,034, down 1% in the last 24 hours.

SHARE: SHARES
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales